MOLECULAR MECHANISMS DISTINGUISH FOLLICULAR ADENOMA/FOLLICULAR CARCINOMA
MOLECULAR MECHANISMS DISTINGUISH FOLLICULAR ADENOMA/FOLLICULAR CARCINOMA
批准号:
6275528
负责人:
MARTHA A ZEIGER
金额:
$2.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Over 28,000 thyroidectomies are performed in the United States annually
for suspected malignancy. However, up to 18,000 of these are benign on
permanent histology. This phenomenon is due to the fact that fine
needle aspirations (FNA) of the thyroid that are suspicious for
malignancy ultimately turn out to represent a benign process in 60% of
cases. Because of this phenomenon we chose to examine follicular
neoplasms of the thyroid for molecular markers that would distinguish
a follicular adenoma from a carcinoma. Up to 40 follicular neoplasms
of the thyroid were screened by microsatellite polymorphism analysis
that might distinguish the two. Although there was no difference
between follicular adenomas and follicular carcinomas, Hijrthle cell
neoplasms of the thyroid appeared to have greater loss of heterozygosity
on chromosomes 1q and 2p that could distinguish Hijrthle cell adenomas
from Hijrthle cell carcinomas. These abnormalities could also be
demonstrated on FNA samples with 100% sensitivity and 75% specificity;
a potential dramatic improvement over what can now be accomplished by
cytology.
Because Hiirthle cell neoplasms of the thyroid represent a very small
percentage of thyroid carcinomas that still left the clinical dilemma
of distinguishing follicular adenomas from carcinomas as well as lesions
that were suspicious for papillary thyroid carcinoma. We, therefore,
examined follicular neoplasms and lesions that were suspicious for
papillary cancer for telomerase activity. We found that 100% of
follicular carcinomas and 67% of papillary thyroid cancer have a
positive telomerase activity. As a result of this above work, we are
prospectively collecting FNA samples from patients who have suspicious
lesions on thyroid cytology. The collaborating institutions include
the University of Pittsburgh and Mayo Clinic at Jacksonville. To date
we have collected 127 samples and are currently examining the use of
telomerase as a marker to distinguish benign from malignant. Should we
be able to accomplish this and apply it to FNA then theoretically this
technique could result in the obviation of up to 18,000 thyroidectomies
performed annually in this country.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR MECHANISMS DISTINGUISH FOLLICULAR ADENOMA/FOLLICULAR CARCINOMA
-
批准号:6114293
-
项目类别:
-
资助金额:$2.06万
-
财政年份:1998
-
负责人:MARTHA A ZEIGER
-
依托单位:
MOLECULAR MECHANISMS DISTINGUISH FOLLICULAR ADENOMA/FOLLICULAR CARCINOMA
-
批准号:6218204
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:MARTHA A ZEIGER
-
依托单位:
MOLECULAR MECHANISMS DISTINGUISH FOLLICULAR ADENOMA/FOLLICULAR CARCINOMA
-
批准号:6297507
-
项目类别:
-
资助金额:$0.23万
-
财政年份:1998
-
负责人:MARTHA A ZEIGER
-
依托单位:
MOLECULAR MECHANISMS DISTINGUISH FOLLICULAR ADENOMA/FOLLICULAR CARCINOMA/THYROID
-
批准号:6245438
-
项目类别:
-
资助金额:$2.23万
-
财政年份:1997
-
负责人:MARTHA A ZEIGER
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: